This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Herwaarden, A. E.
Right arrow Articles by Schinkel, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Herwaarden, A. E.
Right arrow Articles by Schinkel, A. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2007, p. 1247-1253, Vol. 27, No. 4
0270-7306/07/$08.00+0     doi:10.1128/MCB.01621-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk{triangledown}

Antonius E. van Herwaarden,1 Els Wagenaar,1 Gracia Merino,1,{dagger} Johan W. Jonker,1,{ddagger} Hilde Rosing,2 Jos H. Beijnen,2 and Alfred H. Schinkel1*

Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands,1 Department of Pharmacy and Pharmacology, Slotervaart Hospital, 1066 EC Amsterdam, The Netherlands2

Received 31 August 2006/ Returned for modification 13 November 2006/ Accepted 27 November 2006

The multidrug transporter breast cancer resistance protein (BCRP/ABCG2) is strongly induced in the mammary gland during pregnancy and lactation. We here demonstrate that BCRP is responsible for pumping riboflavin (vitamin B2) into milk, thus supplying the young with this important nutrient. In Bcrp1–/– mice, milk secretion of riboflavin was reduced >60-fold compared to that in wild-type mice. Yet, under laboratory conditions, Bcrp1–/– pups showed no riboflavin deficiency due to concomitant milk secretion of its cofactor flavin adenine dinucleotide, which was not affected. Thus, two independent secretion mechanisms supply vitamin B2 equivalents to milk. BCRP is the first active riboflavin efflux transporter identified in mammals and the first transporter shown to concentrate a vitamin into milk. BCRP activity elsewhere in the body protects against xenotoxins by reducing their absorption and mediating their excretion. Indeed, Bcrp1 activity increased excretion of riboflavin into the intestine and decreased its systemic availability in adult mice. Surprisingly, the paradoxical dual utilization of BCRP as a xenotoxin and a riboflavin pump is evolutionarily conserved among mammals as diverse as mice and humans. This study establishes the principle that an ABC transporter can transport a vitamin into milk and raises the possibility that other vitamins and nutrients are likewise secreted into milk by ABC transporters.

* Corresponding author. Mailing address: Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Phone: 31-20-5122046. Fax: 31-20-5122050. E-mail: a.schinkel{at}nki.nl.

{triangledown} Published ahead of print on 4 December 2006.

{dagger} Present address: Department of Physiology, Faculty of Veterinary Medicine, University of Leon, Campus de Vegazana s/n, 24071 León, Spain.

{ddagger} Present address: The Salk Institute for Biological Studies, Howard Hughes Medical Institute, 10010 N. Torrey Pines Rd., La Jolla, CA 92037.

Molecular and Cellular Biology, February 2007, p. 1247-1253, Vol. 27, No. 4
0270-7306/07/$08.00+0     doi:10.1128/MCB.01621-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Delou, J. M. A., Lopes, A. G., Capella, M. A.M. (2009). Unveiling the Role of Multidrug Resistance Proteins in Hypertension. Hypertension 54: 210-216 [Full Text]  
  • Zhang, Y., Byun, Y., Ren, Y. R., Liu, J. O., Laterra, J., Pomper, M. G. (2009). Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging-Based High-Throughput Assay. Cancer Res. 69: 5867-5875 [Abstract] [Full Text]  
  • Merino, G., Real, R., Baro, M. F., Gonzalez-Lobato, L., Prieto, J. G., Alvarez, A. I., Marques, M. M. (2009). Natural Allelic Variants of Bovine ATP-Binding Cassette Transporter ABCG2: Increased Activity of the Ser581 Variant and Development of Tools for the Discovery of New ABCG2 Inhibitors. Drug Metab. Dispos. 37: 5-9 [Abstract] [Full Text]  
  • de Wolf, C., Jansen, R., Yamaguchi, H., de Haas, M., van de Wetering, K., Wijnholds, J., Beijnen, J., Borst, P. (2008). Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. Molecular Cancer Therapeutics 7: 3092-3102 [Abstract] [Full Text]  
  • Poonkuzhali, B., Lamba, J., Strom, S., Sparreboom, A., Thummel, K., Watkins, P., Schuetz, E. (2008). Association of Breast Cancer Resistance Protein/ABCG2 Phenotypes and Novel Promoter and Intron 1 Single Nucleotide Polymorphisms. Drug Metab. Dispos. 36: 780-795 [Abstract] [Full Text]  
  • Shukla, S., Wu, C.-P., Nandigama, K., Ambudkar, S. V. (2007). The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Molecular Cancer Therapeutics 6: 3279-3286 [Abstract] [Full Text]  
  • Vogl, C., Grill, S., Schilling, O., Stulke, J., Mack, M., Stolz, J. (2007). Characterization of Riboflavin (Vitamin B2) Transport Proteins from Bacillus subtilis and Corynebacterium glutamicum. J. Bacteriol. 189: 7367-7375 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»